Biomarkers along the continuum of care in lung cancer
Scand J Clin Lab Invest
2016
76 245
S40-S45
The role of cell-free nucleic acid diagnostics in clinical chemistry and pathology
LaboratoriumsMedizin
2016
40
5
291-292
HMGB1, nucleosomes and sRAGE as new prognostic serum markers after multiple trauma
LaboratoriumsMedizin
2016
40
3
165-173
A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.
J Nanobiotechnology
2016
14
1
57
Blood-based biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
Clin Chim Acta
2016
455
26-32
Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trial.
BMC Fam Pract
2016
17
49
Paradoxical Role of HMGB1 in Pancreatic Cancer: Tumor Suppressor or Tumor Promoter?
Anticancer Res
2016
36
9
4381-9
Prognostic Value of High-sensitivity Troponin T After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease.
Rev Esp Cardiol (Engl Ed)
2016
69
8
746-53